Abstract:Background: The picosecond 755-nm alexandrite laser and topical tranexamic acid (TA) have shown promise in treating melasma. Aim: This aim of this study was to evaluate the efficacy and safety of combining to a picosecond 755-nm alexandrite laser combined with topical TA for melasma treatment. Patients and methods: Forty-eight patients' facial halves with bilateral symmetrical melasma were randomized to receive either topical TA and picosecond laser treatment or laser monotherapy. All patients received three consecutive picosecond laser treatment sessions at 4-week intervals, and additional one side facial received topical TA treatment twice daily until 4 weeks after the third treatments. Efficacy was assessed using the Modified Melasma Area and Severity Index (mMASI) score, VISIA (Canfield, USA) red area feature counts, and average pore volume as measured by Antera 3D®. Patient satisfaction was evaluated through questionnaires. Results: Thirty-five patients completed the study. Post-treatment, mMASI scores and VISIA red area feature counts were lower in combination therapy halves and laser monotherapy halves, and average melanin level was lower in the combination therapy halves (p < 0.05). Comparisons between the combination therapy halves and laser monotherapy halves after the third treatment revealed significant differences in mMASI scores, melanin levels, and VISIA red area feature counts (p < 0.05). After treatment, patient satisfaction rates in the combination therapy halves and monotherapy halves was 71.4% and 54.3%, respectively (p < 0.05). No obvious adverse effects were observed in the combination therapy halves; whereas, 10.42% (5/48) of participants in the laser monotherapy halves experienced temporary pigmentation, which resolved within 3 months. Conclusion: The picosecond 755-nm alexandrite laser, when used independently and in combination with topical TA, has been proven to be effective in the improvement of melasma. However, the combined treatment approach showed a more pronounced improvement in melasma symptoms, with higher patient satisfaction, and was associated with a lower incidence of adverse effects. These findings strongly support that integrating topical TA with picosecond laser therapy as a superior therapeutic strategy for melasma management. Clinical trial registration: Chinese Clinical Trial Registry: ChiCTR2200057771.

Efficacy and Safety of Intense Pulsed Light in Treatment of Melasma in Chinese Patients

Application of a Novel Intense Pulsed Light Device on Melasma Lesions

A Meta-analysis-Based Assessment of Intense Pulsed Light for Treatment of Melasma

A Combination Treatment of Drug‐laser‐photon for Melasma: A Retrospective Study of Clinical Cases

Application of a New Intense Pulsed Light Device in the Treatment of Photoaging Skin in Asian Patients.

Combination of Fractional QSRL and IPL for Melasma Treatment in Chinese Population

Efficacy and Safety of Low-Fluence 730-nm Picosecond Laser in the Treatment of Melasma in Chinese Patients

Efficacy and Safety of Fluocinolone Acetonide, Hydroquinone, and Tretinoin Cream in Chinese Patients with Melasma: a Randomized, Double-Blind, Placebo-Controlled, Multicenter, Parallel-Group Study.

Clinical Effect of Laser and Intense Pulsed Light in the Treatment of Melasmas

Tranexamic Acid and Β-Glucan Ultrasonic Combined with Intense Pulsed Light in the Treatment of Facial Melasma

A Split-Face Study of Intense Pulsed Light on Photoaging Skin in Chinese Population

Efficacy and Safety of Fractional Q-switched 1064-Nm Neodymium-Doped Yttrium Aluminum Garnet Laser in the Treatment of Melasma in Chinese Patients.

Efficacy and Safety of Q-Switched 1,064-Nm Neodymium-Doped Yttrium Aluminum Garnet Laser Treatment of Melasma

Efficacy and Safety of Laser‐related Therapy for Melasma: A Systematic Review and Network Meta‐analysis

Observation of a Novel Intense Pulsed Light Device on the Treatment of Melasma Lesions-a SPLIT-FACE Study

Combined Efficacy of Q-Switched 785 nm Laser and Tranexamic Acid Cream in the Treatment of Melasma: A Prospective Clinical Study

Fractional Photothermolysis Technology in Treatment of Melasma

The dual toning technique of 1064nm Nd:YAG picosecond and quasi-long pulsed laser combined with D-pigment cream in treatment of melasma

Effectiveness of Picosecond 755 nm Alexandrite Laser for the Treatment of Melasma

Clinical treatment of patients accompanied with facial freckles and melasma by means of intense pulsed light with optimal pulse technology

Safety and efficacy of a picosecond 755-nm alexandrite laser combined with topical tranexamic acid in the treatment of melasma